XML 120 R101.htm IDEA: XBRL DOCUMENT v3.25.0.1
Investments in and Advances to Unconsolidated Joint Ventures - Narrative (Details)
$ in Millions
1 Months Ended 12 Months Ended
Aug. 01, 2022
USD ($)
property
Jan. 31, 2024
USD ($)
property
Dec. 31, 2024
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
Schedule of Equity Method Investments [Line Items]          
Difference between carrying amount and underlying equity     $ 42   $ 49
Gain (loss) on deconsolidation     $ 78 $ 311  
Life Science Joint Venture In San Francisco, California | Lab          
Schedule of Equity Method Investments [Line Items]          
Investment ownership percentage 70.00%        
Property count | property 7        
Callan Ridge JV | Lab          
Schedule of Equity Method Investments [Line Items]          
Property count | property   2      
Life Science Joint Venture In San Francisco, California | Life Science Joint Venture In San Francisco, California | Lab          
Schedule of Equity Method Investments [Line Items]          
Investment ownership percentage 30.00%        
Cash proceeds $ 126        
Callan Ridge JV | Callan Ridge JV          
Schedule of Equity Method Investments [Line Items]          
Investment ownership percentage   35.00%      
Callan Ridge JV | Callan Ridge JV | Lab          
Schedule of Equity Method Investments [Line Items]          
Investment ownership percentage   65.00%      
Cash proceeds   $ 128